查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1416735

輔助人工心臟市場報告：2030 年趨勢、預測與競爭分析

Ventricular Assist Device Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

輔助人工心臟的趨勢與預測

預計到 2030 年，全球輔助人工心臟市場將達到 32 億美元，2024 年至 2030 年年複合成長率為 10.5%。該市場的關鍵促進因素是心臟衰竭盛行率的上升和心血管疾病患者數量的增加。全球輔助人工心臟市場的未來看起來充滿希望，在橋接移植、目的地治療、橋接恢復和橋接治療應用方面存在機會。

輔助人工心臟市場洞察

Lucintel 預測，由於心臟病患者擴大使用植入式心室輔助人工心臟將出現更高的成長。

在這個市場中，目的地治療預計將經歷最高的成長。

由於該地區擁有強大的醫療保健系統和主要企業，預計北美地區將在預測期內實現最高的成長。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球輔助人工心臟市場預計將達到 32 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球輔助人工心臟市場預計將以10.5%的年複合成長率成長。

Q3.影響市場成長的關鍵促進因素是：

A3. 該市場的關鍵促進因素是心臟衰竭盛行率的上升和心血管疾病患者數量的增加。

Q4.市場的主要細分市場是：

A4.輔助人工心臟市場的未來看起來很有希望，在移植橋、目的地治療、恢復橋和治療橋應用方面都有機會。

Q5.市場的主要企業是：

A5. 主要的輔助人工心臟公司如下。

  • Abbott Laboratories
  • Corewave
  • Bivacor
  • Carmat
  • Jarvik Heart

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，由於心臟病患者擴大使用植入式心室輔助人工心臟預計將出現更高的成長。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 由於該地區擁有強大的醫療保健系統和主要企業，預計北美地區將在預測期內實現最高的成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 列出了 10% 的客製化服務，無需額外費用。

目錄

第1章執行摘要

第2章全球輔助人工心臟市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球輔助人工心臟市場趨勢（2018-2023）與預測（2024-2030）
  • 全球輔助人工心臟市場的設計
    • 經皮心室輔助裝置
    • 植入式輔助人工心臟
  • 按產品分類的全球輔助人工心臟市場
    • 左心室輔助裝置 (LVAD)
    • 右心室輔助裝置 (RVAD)
    • 雙心室輔助裝置（BIVAD）
  • 全球輔助人工心臟市場（按應用）
    • 移植的橋樑
    • 目的地治療
    • 恢復的橋樑
    • 通往候選療法的橋樑
  • 全球輔助人工心臟市場（依最終用途）
    • 門診手術中心
    • 醫院
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球輔助人工心臟市場（按地區）
  • 北美輔助人工心臟市場
  • 歐洲輔助人工心臟市場
  • 亞太心室輔助人工心臟市場
  • 其他地區輔助人工心臟市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球輔助人工心臟市場設計成長機會
    • 全球輔助人工心臟市場成長機會（按產品）
    • 全球輔助人工心臟市場成長機會（按應用）
    • 全球輔助人工心臟市場成長機會（依最終用途）
    • 全球輔助人工心臟市場成長機會（按地區）
  • 全球輔助人工心臟市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球輔助人工心臟市場的產能
    • 全球輔助人工心臟市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Abbott Laboratories
  • Corewave
  • Bivacor
  • Carmat
  • Jarvik Heart
簡介目錄

Ventricular Assist Device Trends and Forecast

The future of the global ventricular assist device market looks promising with opportunities in the bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy applications. The global ventricular assist device market is expected to reach an estimated $3.2 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are rising prevalence of heart failure and growing number of patients with cardiovascular disease.

A more than 150-page report is developed to help in your business decisions.

Ventricular Assist Device by Segment

The study includes a forecast for the global ventricular assist device by design, product, application, end use, and region.

Ventricular Assist Device Market by Design [Shipment Analysis by Value from 2018 to 2030]:

  • Transcutaneous Ventricular Assist Devices
  • Implantable Ventricular Assist Devices

Ventricular Assist Device Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Left Ventricular Assist Devices (LVADs)
  • Right Ventricular Assist Devices (RVADs)
  • Biventricular Assist Devices (BIVADs)

Ventricular Assist Device Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Bridge-to-Transplant
  • Destination Therapy
  • Bridge-to-Recovery
  • Bridge to Candidacy Therapy

Ventricular Assist Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Ambulatory Surgery Centers
  • Hospital
  • Others

Ventricular Assist Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Ventricular Assist Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ventricular assist device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ventricular assist device companies profiled in this report include-

  • Abbott Laboratories
  • Corewave
  • Bivacor
  • Carmat
  • Jarvik Heart

Ventricular Assist Device Market Insights

Lucintel forecasts that implantable ventricular assist device is expected to witness the higher growth over the forecast period due to its rising usage among patients with heart issue to improve the pumping function of the heart.

Within this market, destination therapy is expected to witness the highest growth.

North America is expected to witness highest growth over the forecast period due to existence of strong healthcare system and presence of key players in the region.

Features of the Global Ventricular Assist Device Market

Market Size Estimates: Ventricular assist device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Ventricular assist device market size by various segments, such as by design, product, application, end use, and region in terms of value ($B).

Regional Analysis: Ventricular assist device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different designs, products, applications, end uses, and regions for the ventricular assist device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ventricular assist device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the ventricular assist device market size?

Answer: The global ventricular assist device market is expected to reach an estimated $3.2 billion by 2030.

Q2. What is the growth forecast for ventricular assist device market?

Answer: The global ventricular assist device market is expected to grow with a CAGR of 10.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the ventricular assist device market?

Answer: The major drivers for this market are rising prevalence of heart failure and growing number of patients with cardiovascular disease.

Q4. What are the major segments for ventricular assist device market?

Answer: The future of the ventricular assist device market looks promising with opportunities in the bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy applications.

Q5. Who are the key ventricular assist device market companies?

Answer: Some of the key ventricular assist device companies are as follows:

  • Abbott Laboratories
  • Corewave
  • Bivacor
  • Carmat
  • Jarvik Heart

Q6. Which ventricular assist device market segment will be the largest in future?

Answer: Lucintel forecasts that implantable ventricular assist device is expected to witness the higher growth over the forecast period due to its rising usage among patients with heart issue to improve the pumping function of the heart.

Q7. In ventricular assist device market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of strong healthcare system and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the ventricular assist device market by design (transcutaneous ventricular assist devices and implantable ventricular assist devices), product (left ventricular assist devices, right ventricular assist devices, and biventricular assist devices), application (bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy), end use (ambulatory surgery centers, hospital, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Ventricular Assist Device Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Ventricular Assist Device Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Ventricular Assist Device Market by Design
    • 3.3.1: Transcutaneous Ventricular Assist Devices
    • 3.3.2: Implantable Ventricular Assist Devices
  • 3.4: Global Ventricular Assist Device Market by Product
    • 3.4.1: Left Ventricular Assist Devices (LVADs)
    • 3.4.2: Right Ventricular Assist Devices (RVADs)
    • 3.4.3: Biventricular Assist Devices (BIVADs)
  • 3.5: Global Ventricular Assist Device Market by Application
    • 3.5.1: Bridge-to-Transplant
    • 3.5.2: Destination Therapy
    • 3.5.3: Bridge-to-Recovery
    • 3.5.4: Bridge to Candidacy Therapy
  • 3.6: Global Ventricular Assist Device Market by End Use
    • 3.6.1: Ambulatory Surgery Centers
    • 3.6.2: Hospital
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Ventricular Assist Device Market by Region
  • 4.2: North American Ventricular Assist Device Market
    • 4.2.2: North American Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
  • 4.3: European Ventricular Assist Device Market
    • 4.3.1: European Ventricular Assist Device Market by Design: Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices
    • 4.3.2: European Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
  • 4.4: APAC Ventricular Assist Device Market
    • 4.4.1: APAC Ventricular Assist Device Market by Design: Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices
    • 4.4.2: APAC Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
  • 4.5: ROW Ventricular Assist Device Market
    • 4.5.1: ROW Ventricular Assist Device Market by Design: Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices
    • 4.5.2: ROW Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Ventricular Assist Device Market by Design
    • 6.1.2: Growth Opportunities for the Global Ventricular Assist Device Market by Product
    • 6.1.3: Growth Opportunities for the Global Ventricular Assist Device Market by Application
    • 6.1.4: Growth Opportunities for the Global Ventricular Assist Device Market by End Use
    • 6.1.5: Growth Opportunities for the Global Ventricular Assist Device Market by Region
  • 6.2: Emerging Trends in the Global Ventricular Assist Device Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Ventricular Assist Device Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Ventricular Assist Device Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: Corewave
  • 7.3: Bivacor
  • 7.4: Carmat
  • 7.5: Jarvik Heart